Holen Sie sich die Stockscreener-App
130.74
3.19%
-4.31
Handel nachbörslich:
131.01
0.27
+0.21%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ILMN?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$135.05
Offen:
$135
24-Stunden-Volumen:
2.49M
Relative Volume:
1.44
Marktkapitalisierung:
$20.74B
Einnahmen:
$4.39B
Nettoeinkommen (Verlust:
$-1.58B
KGV:
-4.9132
EPS:
-26.61
Netto-Cashflow:
$546.00M
1W Leistung:
-13.70%
1M Leistung:
-10.49%
6M Leistung:
+17.71%
1J Leistung:
+38.61%
1-Tages-Spanne:
$129.71
$135.53
1-Wochen-Bereich:
$129.71
$151.70
52-Wochen-Spanne:
$93.39
$156.66
Illumina Inc Stock (ILMN) Company Profile
Firmenname
Illumina Inc
Sektor
Branche
Telefon
(858) 202-4500
Adresse
5200 ILLUMINA WAY, SAN DIEGO, CA
Vergleichen Sie ILMN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
| ILMN | 130.74 | 20.74B | 4.39B | -1.58B | 546.00M | -26.61 |
| TMO | 501.29 | 192.46B | 42.37B | 6.14B | 7.78B | 15.26 |
| DHR | 230.06 | 166.23B | 23.74B | 3.89B | 4.98B | 7.93 |
| A | 126.92 | 36.47B | 6.50B | 1.41B | 1.42B | 3.82 |
| IQV | 191.04 | 34.67B | 15.32B | 1.41B | 1.96B | 5.95 |
| IDXX | 419.83 | 34.38B | 3.84B | 866.24M | 792.60M | 9.80 |
Illumina Inc Stock (ILMN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-01-16 | Herabstufung | HSBC Securities | Buy → Hold |
| 2024-01-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-12-18 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2023-12-15 | Hochstufung | Bernstein | Underperform → Mkt Perform |
| 2023-12-14 | Eingeleitet | Guggenheim | Buy |
| 2023-12-14 | Eingeleitet | Stephens | Overweight |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-12-12 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2023-12-11 | Hochstufung | Citigroup | Sell → Neutral |
| 2023-11-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2023-09-28 | Eingeleitet | Bernstein | Underperform |
| 2023-07-05 | Fortgesetzt | JP Morgan | Neutral |
| 2023-01-25 | Herabstufung | Argus | Buy → Hold |
| 2023-01-05 | Eingeleitet | Scotiabank | Sector Perform |
| 2022-12-12 | Herabstufung | Citigroup | Neutral → Sell |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-04 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2022-09-28 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-07-13 | Herabstufung | Barclays | Equal Weight → Underweight |
| 2022-01-18 | Hochstufung | Stifel | Hold → Buy |
| 2022-01-11 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2022-01-07 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-06 | Fortgesetzt | Morgan Stanley | Equal-Weight |
| 2022-01-06 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-19 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2021-06-01 | Hochstufung | Evercore ISI | Underperform → In-line |
| 2021-03-31 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2021-03-31 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2021-03-03 | Eingeleitet | Barclays | Underweight |
| 2020-12-22 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-17 | Hochstufung | BTIG Research | Neutral → Buy |
| 2020-10-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-29 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2020-09-22 | Herabstufung | Stifel | Buy → Hold |
| 2020-09-22 | Herabstufung | UBS | Buy → Neutral |
| 2020-09-21 | Hochstufung | Guggenheim | Neutral → Buy |
| 2020-09-21 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-09-09 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2020-08-07 | Herabstufung | Evercore ISI | In-line → Underperform |
| 2020-08-07 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2020-07-07 | Herabstufung | Guggenheim | Buy → Neutral |
| 2020-04-24 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-04-21 | Herabstufung | Robert W. Baird | Outperform → Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Underweight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2020-01-02 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-10-25 | Eingeleitet | Guggenheim | Buy |
Alle ansehen
Illumina Inc Aktie (ILMN) Neueste Nachrichten
How two systems integration scientists ensure a smooth workflow on MiSeq i100 - Illumina
Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now? - Yahoo Finance
Illumina, Inc. (NASDAQ:ILMN) Shares Sold by Mutual of America Capital Management LLC - MarketBeat
CIBC Asset Management Inc Reduces Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
NGS & Microarray Training - Illumina
Impax Asset Management Group plc Increases Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina Inc. stock underperforms Friday when compared to competitors - MarketWatch
North America Bioinformatics Market Statistical Forecast - openPR
ING Groep NV Raises Stake in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Plato Investment Management Ltd Raises Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Oppenheimer & Co. Inc. Has $5.33 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
DNA Test Kits Market Future Business Opportunities 2024-2031 | - openPR
Illumina Inc. stock outperforms competitors despite losses on the day - MarketWatch
12,000 Shares in Illumina, Inc. (NASDAQ:ILMN) Purchased by Freemont Management S.A. - MarketBeat
10,563 Shares in Illumina, Inc. (NASDAQ:ILMN) Bought by Entropy Technologies LP - MarketBeat
Illumina's SWOT analysis: ngs leader faces competition, aims for growth - Investing.com
Biochips Market Is Booming Worldwide 2024-2031 | Illumina, - openPR
Illumina's SWOT analysis: ngs leader faces competition, aims for growth By Investing.com - Investing.com UK
Illumina Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Urban Illumina 2024 at MDI Gurgaon Illuminates Insights, Entertainment, and Engagement through Disguised Market Research - Passionate In Marketing
Single-cell RNA analysis finds possible genetic drivers of bone cancer - Illumina
Mengis Capital Management Inc. Purchases New Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Consumer Genomics Industry Next Big Thing | Major Giants- Veritas, Illumina, Xcode Life - openPR
Illumina Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
OVERSEA CHINESE BANKING Corp Ltd Sells 39,734 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina (NASDAQ:ILMN) Receives Equal Weight Rating from Morgan Stanley - MarketBeat
Illumina, Inc. (NASDAQ:ILMN) Stock Holdings Cut by Baillie Gifford & Co. - MarketBeat
Bioinformatics Services Market: Size, Share, Trends, - openPR
Los Angeles Capital Management LLC Boosts Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Illumina, Inc. (ILMN): Unlocking Growth Potential in Genetic Testing and Robotics - Insider Monkey
Illumina Inc. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
WCM Investment Management LLC Has $424.48 Million Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Neuroscience Market Projected to Reach USD 50.2 Billion by 2032, Growing at a 4.0% CAGR – S&S Insider - GlobeNewswire Inc.
Why Illumina (ILMN) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Piper Sandler Issues Pessimistic Forecast for Illumina (NASDAQ:ILMN) Stock Price - MarketBeat
Biological Multiplex Assays Market Report Analysis - openPR
Ownership Capital B.V. Sells 181,945 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Principal Financial Group Inc. Lowers Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Trend Tracker for (ILMN) - Stock Traders Daily
Carmel Capital Partners LLC Decreases Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Kornitzer Capital Management Inc. KS Has $2.75 Million Stock Holdings in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Here’s Why You Should Invest in Illumina (ILMN) - Insider Monkey
Illumina signs MoU with PHASE to Advance Oncology Testing in the Greater Bay Area and Contribute to the ''Healthy China'' - PR Newswire
AIA Group Ltd Increases Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
NHS Wales partners with Illumina on genomics drive - pharmaphorum
Illumina Inc. stock outperforms competitors on strong trading day - MarketWatch
Interpreting Illumina (ILMN) International Revenue Trends - Yahoo Finance
Q4 Earnings Estimate for Illumina Issued By Leerink Partnrs - MarketBeat
Radnor Capital Management LLC Invests $910,000 in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Asset Management One Co. Ltd. Acquires 6,971 Shares of Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
National Pension Service Boosts Stock Position in Illumina, Inc. (NASDAQ:ILMN) - MarketBeat
Finanzdaten der Illumina Inc-Aktie (ILMN)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.83%
1.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):